Search results
Author(s):
Suzanne J Baron
Added:
7 months ago
TCT 2025 — Dr Suzanne J Baron (Massachusetts General Hospital, US), principal investigator of the Short-CUT trial (NCT06089135; Baim Institute for Clinical Research), joins us to discuss this investigator-initiated, multicentre randomized controlled study.The trial enrolled 410 patients with moderate to severe coronary artery calcification across up to 22 international sites. Eligible…
View more
Author(s):
Nicolas M Van Mieghem
Added:
1 week ago
EuroPCR 2026 — Professor Nicolas Van Mieghem joins us to discuss the FRACTURE trial, which evaluated the safety and effectiveness of the laser-based Seismic intravascular lithotripsy (IVL) system for the treatment of severely calcified coronary lesions.The FRACTURE trial was designed to support both FDA IDE and CE mark regulatory approval. It prospectively enrolled 440 patients, with a primary…
View more
Author(s):
Matthias Bossard
Added:
7 months ago
TCT 2025 - The randomized VICTORY Study finds OCT-guided PCI involving lesion preparation with the OPN super-high-pressure non-compliant balloon is non-inferior to intravascular lithotropsy.Dr Matthias Bossard (Kantonsspital Lucerne, Lucerne, CH) joins us to discuss findings from the VICTORY Trial, a randomized, multicenter, non-inferiority comparison evaluating intravascular lithotripsy versus…
View more
Getting More from IVL Technology
Author(s):
Anirban Choudhury
,
Majd B Protty
,
Hussain Hussain
,
et al
Added:
7 months ago
Expert Opinion
Avtandil Babunashvili
Job title: Head of Department (Cardiovascular Surgery)
Author
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
2 years ago
What's hot at EuroPCR 2024?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.What is the potential impact of the new data on practice? What details should we look out for? What is the context of the EuroPCR trials?Trials covered included:00…
View more
RotaShock Series
Author(s):
Jonathan Hinton
,
Rajesh Varma
,
Jehangir Din
,
et al
Added:
1 year ago
Original Research
Author(s):
Nicolas M Van Mieghem
Added:
1 month ago
In this EuroPCR 2026 preview, Prof Nicolas Van Mieghem (Erasmus University, NL) walks through the most anticipated late-breaking trials across calcified coronary disease, structural heart intervention, and mechanical support — from laser-based IVL and atherectomy comparisons to three-year TAVI outcomes, tricuspid repair, high-risk PCI, and pulmonary embolism therapy.Editor: Mirjam Boros
View more
Author(s):
Andrew Holden
Added:
1 year ago
What are the unique features of the new intravascular lithotripsy (IVL) devices addressing calcified tibial disease?Prof Andrew Holden (Auckland City Hospital, Auckland, NZ) joins us to discuss two new devices addressing calcified tibial disease, the Shockwave E8 catheter and the Shockwave Javelin catheter. Prof Holden then evaluates the safety and efficacy findings from the Disrupt PAD BTK II…
View more